PEG-Intron Plus Rebetol Treatment of Chronic Hepatitis C Subjects Who Failed Response to Alpha-Interferon Plus Ribavirin (Study P02370)

NCT00039871 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2333

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis
Hepatitis C, Chronic
Fibrosis
Liver Cirrhosis

Interventions

BIOLOGICAL: PegIntron (peginterferon alfa-2b; SCH 54031)
DRUG: REBETOL (ribavirin; SCH 18908)

Sponsor

Merck Sharp & Dohme LLC